Rosiglitazone, a.k.a. the diabetes drug avandia, improves anti-tumor effect of platinum-based chemotherapy

被引：0
|
作者：
不详
机构：
来源：
CANCER BIOLOGY & THERAPY | 2007年 / 6卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：819 / 820
页数：2
相关论文
共 27 条
  • [21] DRUG-CARRIER PROPERTY OF ALBUMIN MICROSPHERES IN CHEMOTHERAPY .5. ANTI-TUMOR EFFECT OF MICROSPHERE-ENTRAPPED ADRIAMYCIN ON LIVER METASTASIS OF AH-7974 CELLS IN RATS
    MORIMOTO, Y
    SUGIBAYASHI, K
    KATO, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1981, 29 (05) : 1433 - 1438
  • [22] Low molecular weight chitosan based GSH-responsive self-assembled cationic micelle with enhanced anti-tumor effect by combining oxidative damage and chemotherapy
    Yuan, Yuting
    Chen, Qiuhong
    Wang, Zhenhua
    Mi, Yingqi
    Dong, Fang
    Tan, Wenqiang
    Guo, Zhanyong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 268
  • [23] A Pooled Exploratory Analysis of the Effect of Tumor Size on Survival Benefit from Adjuvant Platinum-based Chemotherapy (ACT) in Node Negative (N0) Non-small Cell Lung Cancer (NSCLC)
    Cuffe, S.
    Ezzalfani, M.
    Graziano, S.
    Pignon, J.
    Seymour, L.
    Strevel, E.
    Burkes, R.
    Shepherd, F. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S512 - S512
  • [24] Enhanced anti-tumor activity of an Auristatin-based antibody-drug conjugate in combination with PI3K/mTOR inhibitors or taxanes: Translational implications and mechanistic insights
    Sapra, Puja
    Shor, Boris
    Dougher, Maureen
    Kahler, Jennifer
    Mack, Michelle
    Xu, Jane
    Lu, Shuyan
    Melamud, Eugene
    Wang, Fang
    Rostjord, Edward
    CANCER RESEARCH, 2015, 75
  • [25] DRUG-CARRIER PROPERTY OF ALBUMIN MICROSPHERES IN CHEMOTHERAPY .4. ANTI-TUMOR EFFECT OF SINGLE-SHOT OR MULTIPLE-SHOT ADMINISTRATION OF MICROSPHERE-ENTRAPPED 5-FLUOROURACIL ON EHRLICH ASCITES OR SOLID TUMOR IN MICE
    MORIMOTO, Y
    AKIMOTO, M
    SUGIBAYASHI, K
    NADAI, T
    KATO, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1980, 28 (10) : 3087 - 3092
  • [26] An open-label, single-center phase II trial of cadonilimab (an anti-PD-1/CTLA-4 bispecific antibody) in combination with platinum-based dual-drug neoadjuvant chemotherapy for locally advanced, resectable head and neck squamous cell carcinoma
    Cao, Fei
    Wu, Di
    Xu, PengFei
    Fang, Qi
    Zhao, Zheng
    Zhang, Xinrui
    Yan, Honghong
    Jiang, Ke
    Zhou, Jian
    Li, Yan
    Lu, Li-Xia
    Chen, Chunyan
    Han, Fei
    Li, Zhiming
    Liu, Xuekui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Dual inhibition of mTOR and of the insulin like growth factor receptor-1 completely blocks the PI3K/Akt/mTOR pathway and results in a supra-additive anti-tumor effect: a mechanistic-based combination approach
    Di Cosimo, S.
    Scaltriti, M.
    Rojo, F.
    Val, D.
    Guzman, M.
    Seoane, J.
    Jimenez, J.
    Arribas, J.
    Cognetti, F.
    Baselga, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 428 - 428
123